We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$17.3B
AUM Growth
+$1.81B
Cap. Flow
+$429M
Cap. Flow %
2.48%
Top 10 Hldgs %
36.04%
Holding
650
New
35
Increased
221
Reduced
232
Closed
37

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$45.5M
2
PG icon
Procter & Gamble
PG
+$43.7M
3
TMO icon
Thermo Fisher Scientific
TMO
+$37.7M
4
MRSH
Marsh
MRSH
+$35.6M
5
MSFT icon
Microsoft
MSFT
+$28.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$47.8M
2
C icon
Citigroup
C
+$29.8M
3
DFS
Discover Financial Services
DFS
+$23.8M
4
RY icon
Royal Bank of Canada
RY
+$16.8M
5
TRI icon
Thomson Reuters
TRI
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 23.29%
2 Financials 18.67%
3 Healthcare 12.74%
4 Consumer Discretionary 10.75%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOXL icon
501
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$18.7B
$279K ﹤0.01%
+6,000
New +$230K
MAR icon
502
Marriott International
MAR
$98.7B
$278K ﹤0.01%
1,102
+155
+16% +$37.5K
OIH icon
503
VanEck Oil Services ETF
OIH
$2.06B
$276K ﹤0.01%
820
AG icon
504
First Majestic Silver
AG
$8.05B
$275K ﹤0.01%
46,692
-6,500
-12% -$32.6K
GRMN
505
Garmin
GRMN
$46.9B
$272K ﹤0.01%
1,830
ROK icon
506
Rockwell Automation
ROK
$51.4B
$272K ﹤0.01%
932
+280
+43% +$80.6K
GILD icon
507
Gilead Sciences
GILD
$161B
$270K ﹤0.01%
3,692
-493
-12% -$37.9K
TRV icon
508
Travelers Companies
TRV
$80.8B
$268K ﹤0.01%
+1,166
New +$249K
KMI icon
509
Kinder Morgan
KMI
$73.1B
$264K ﹤0.01%
14,414
VALE icon
510
Vale
VALE
$62.9B
$263K ﹤0.01%
+21,590
New +$291K
TDG icon
511
TransDigm Group
TDG
$69.2B
$259K ﹤0.01%
210
+5
+2% +$5.63K
INDY icon
512
iShares S&P India Nifty 50 Index Fund
INDY
$545M
$258K ﹤0.01%
5,120
-150
-3% -$7.48K
ERO icon
513
Ero Copper
ERO
$2.71B
$257K ﹤0.01%
13,333
VRNA
514
DELISTED
Verona Pharma
VRNA
$257K ﹤0.01%
15,976
HYGH icon
515
iShares Interest Rate Hedged High Yield Bond ETF
HYGH
$573M
$257K ﹤0.01%
2,994
ITOT icon
516
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
$255K ﹤0.01%
2,213
AWK icon
517
American Water Works
AWK
$26.3B
$254K ﹤0.01%
2,075
-150
-7% -$18.5K
SJM icon
518
J.M. Smucker
SJM
$12.6B
$252K ﹤0.01%
2,000
UUUU icon
519
Energy Fuels
UUUU
$2.82B
$249K ﹤0.01%
39,620
AIG icon
520
American International
AIG
$41.9B
$249K ﹤0.01%
3,185
GM icon
521
General Motors
GM
$74.7B
$248K ﹤0.01%
+5,478
New +$212K
NXE icon
522
NexGen Energy
NXE
$6.05B
$245K ﹤0.01%
31,531
-1,000
-3% -$7.43K
SLF icon
523
Sun Life Financial
SLF
$45.6B
$245K ﹤0.01%
4,480
-10,960
-71% -$580K
TEI
524
Templeton Emerging Markets Income Fund
TEI
$310M
$244K ﹤0.01%
45,000
RMD icon
525
ResMed
RMD
$28.3B
$244K ﹤0.01%
1,230

Similar funds

Rathbones Group's Q1 2024 Portfolio in Review

As of Q1 2024, Rathbones Group held 650 positions worth $17.3B, up 12% from $15.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Rathbones Group's Q1 2024 filing shows 35 new, 221 increased, 232 reduced and 37 closed positions. Its largest new stake was VanEck Semiconductor ETF: 36,970 shares worth $8.32M. The largest sale was NVIDIA, an estimated $47.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q1 2024 buy was VanEck Semiconductor ETF: 36,970 shares worth $8.32M.
  • Rathbones Group added most to CME Group in Q1 2024, an estimated $45.5M increase.
  • Rathbones Group's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $47.8M.
  • Rathbones Group fully exited Jacobs Solutions in Q1 2024, selling an estimated $4.18M.
  • Rathbones Group's ten largest holdings make up 36% of its $17.3B portfolio in Q1 2024.
  • Rathbones Group opened 35 new positions and closed 37 in Q1 2024.
  • Rathbones Group's portfolio value rose 12% quarter-over-quarter to $17.3B.

Based on Rathbones Group's 13F filing for Q1 2024, filed 14 May 2024.